BRL43694A
\bˌiːˌɑːɹˈɛl fˈɔːtiθɹˈiː θˈa͡ʊzənd sˈɪkshˈʌndɹədən nˈa͡ɪntifˈɔːɹ ˈe͡ɪ], \bˌiːˌɑːɹˈɛl fˈɔːtiθɹˈiː θˈaʊzənd sˈɪkshˈʌndɹədən nˈaɪntifˈɔːɹ ˈeɪ], \b_ˌiː__ˌɑː_ɹ_ˈɛ_l f_ˈɔː_t_i_θ_ɹ_ˈiː θ_ˈaʊ_z_ə_n_d_ s_ˈɪ_k_s_h_ˈʌ_n_d_ɹ_ə_d_ə_n n_ˈaɪ_n_t_i_f_ˈɔː_ɹ ˈeɪ]\
Sort: Oldest first
-
A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic for cancer chemotherapy patients.
By DataStellar Co., Ltd
Word of the day
Olivopontocerebellar Atrophies
- group inherited disorders which share progressive ataxia combination with atrophy CEREBELLUM; PONS; inferior olivary nuclei. Additional features include RIGIDITY; NYSTAGMUS; RETINAL DEGENERATION; MUSCLE SPASTICITY; DEMENTIA; URINARY INCONTINENCE; OPHTHALMOPLEGIA. familial has an earlier onset (second decade) and may feature spinal cord atrophy. sporadic form tends to present in the fifth or sixth decade, is considered a clinical subtype MULTIPLE SYSTEM ATROPHY. (From Adams et al., Principles of Neurology, 6th ed, p1085)